跳至主要内容
临床试验/NCT01983904
NCT01983904已完成不适用

Therapeutic Brain Stimulation for Refractory Depression

University of Calgary2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2013年8月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
Change in Hamilton Depression Rating Scale

研究概览

简要总结

The purpose of this study is to examine the effects of sub-callosal cingulate (SCC) deep brain stimulation (DBS) in patients with treatment resistant depression (TRD).

The working hypotheses are that long pulse-width DBS applied to the SCC region will lead to improvements in TRD patients, and specific neuroimaging biomarkers will correlate with response to DBS; the functional recovery will be enhanced with concurrent cognitive behavioural therapy (CBT).

详细描述

The aim is to collect data on prediction, optimization and augmentation of DBS for TRD and develop tools for DBS surgery. It is a biological pilot study designed to provide informative data for future work.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 20-70
  • diagnosis of major depressive (MDD)or bipolar disorder(BP)determined independently by 2 study psychiatrists
  • current major depressive episode of >1 year duration, treatment-resistant (meaning failure to respond to 4 different classes of antidepressants, including augmentation or combination strategies with lithium, atypical antipsychotics, anticonvulsants, antidepressants, evidence-based psychotherapy, CBT, or electroconvulsive treatment despite adequate dosage, duration and compliance)
  • minimum score of 20 (out of 52) on the 17 item Hamilton Depression Rating Scale (HDRS)
  • resident of Alberta, Canada, covered by Alberta Health

排除标准

  • other Axis I psychiatric disorders including schizophrenia, psychosis, active suicidal ideation over previous 6 months
  • cerebrovascular risk factors, previous stroke, head injury and neurodegenerative disorders, pregnancy, medical and general contraindications for DBS surgery (e.g. cardiac pacemaker/defibrillator)

研究组 & 干预措施

Long Pulse Width

Experimental

deep brain stimulation with short & long pulse width

干预措施: deep brain stimulation with short & long pulse width (Device)

Short Pulse Width

Experimental

deep brain stimulation with short & long pulse width

干预措施: deep brain stimulation with short & long pulse width (Device)

结局指标

主要结局

Change in Hamilton Depression Rating Scale

时间窗: 6 and 12 months post-operatively

change in HDRS from baseline before surgery: rates of remission (defined as an HDRS score \<8 at 6 and 12 months) and response (defined as \>50% reduction in HDRS)

次要结局

  • Change from baseline on Illness Density Index, Montgomery-Asberg Depression Rating Scale and Hamilton Anxiety Scale, Positive and Negative Affect Scale, Clinical Global Impression of Change, GAF< SAs, NAS, Q-LES-Q-SF & neuropsychological tests(6 and 12 months post operatively)
  • Post Cognitive Behavioural Therapy Scores(15 months post operatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zelma Kiss

Associate Professor, Neurosurgery; Director Clinician Investigator Program

University of Calgary

研究点 (2)

Loading locations...

相似试验